Wester; Hans-Jurgen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wester; Hans-Jurgen.The latest application filed is for "cancer diagnostic imaging agents".
- Wester; Hans-Jurgen - Ilmmunster DE
- WESTER; Hans-Jurgen - Schweitenkirchen/Sunzhausen DE
- WESTER; Hans-Jurgen - llmmunster DE
- WESTER; Hans-Jurgen - Munich DE
- Wester; Hans-Jurgen - Immunster DE
- Wester; Hans-Jurgen - Illmmuenster N/A DE
- Wester; Hans-Jurgen - Illmmunster DE
| Patent | Date |
|---|---|
| Dual mode radiotracer and--therapeutics Grant 11,413,360 - Wurzer , et al. August 16, 2 | 2022-08-16 |
| Cancer Diagnostic Imaging Agents App 20220118120 - Wurzer; Alexander Josef ; et al. | 2022-04-21 |
| Psma Binding Dual Mode Radiotracer And Therapeutic App 20220096668 - Wurzer; Alexander Josef ; et al. | 2022-03-31 |
| Silicon-fluoride Acceptor Substituted Radiopharmaceuticals And Precursors Thereof App 20220096669 - DI CARLO; Daniel ; et al. | 2022-03-31 |
| Therapeutic And Diagnostic Agents For Cancer App 20220041674 - OSL; Theresa ; et al. | 2022-02-10 |
| Cxcr4-targeted Diagnostic And Therapeutic Agents With Reduced Species Selectivity App 20220040339 - OSL; Theresa ; et al. | 2022-02-10 |
| Imaging Agents App 20210338841 - VAN LEEUWEN; Fijs W.B. ; et al. | 2021-11-04 |
| Modified cyclopentapeptides and uses thereof Grant 10,919,938 - Wester , et al. February 16, 2 | 2021-02-16 |
| PSMA ligands for imaging and endoradiotherapy App 20200297876 - Wester; Hans-Jurgen ; et al. | 2020-09-24 |
| Dual Mode Radiotracer And -therapeutics App 20200197545 - Wurzer; Alexander Josef ; et al. | 2020-06-25 |
| Compounds binding to neuropathological aggregates Grant 10,328,163 - Wester , et al. | 2019-06-25 |
| Modified Cyclopentapeptides And Uses Thereof App 20180037608 - WESTER; Hans-Jurgen ; et al. | 2018-02-08 |
| Compounds Binding To Neuropathological Aggregates App 20170157274 - WESTER; Hans-Jurgen ; et al. | 2017-06-08 |
| Cyclopentapeptide derivatives and uses thereof Grant 9,266,924 - Demmer , et al. February 23, 2 | 2016-02-23 |
| Triazacyclononane-based phosphinate ligand and its use for molecular imaging Grant 9,260,483 - Notni , et al. February 16, 2 | 2016-02-16 |
| Cancer Imaging and Treatment App 20140100172 - Wester; Hans Jurgen ; et al. | 2014-04-10 |
| Triazacyclononane-based Phosphinate Ligand And Its Use For Molecular Imaging App 20140030820 - Notni; Johannes ; et al. | 2014-01-30 |
| Cancer imaging and treatment Grant 8,628,750 - Wester , et al. January 14, 2 | 2014-01-14 |
| Cancer imaging and treatment Grant 8,614,290 - Wester , et al. December 24, 2 | 2013-12-24 |
| Tc and Re labeled radioactive glycosylated octreotide derivatives Grant 8,575,100 - Wester , et al. November 5, 2 | 2013-11-05 |
| Method For Production Of F-18 Labeled Glutamic Acid Derivatives App 20130149243 - Berndt; Mathias ; et al. | 2013-06-13 |
| Cyclopentapeptide Derivatives And Uses Thereof App 20130129622 - DEMMER; Oliver ; et al. | 2013-05-23 |
| Cancer Imaging And Treatment App 20110027175 - Wester; Hans Jurgen ; et al. | 2011-02-03 |
| Cancer Imaging and Treatment App 20100240072 - Wester; Hans Jurgen ; et al. | 2010-09-23 |
| Chelating Agent App 20100081799 - Knor; Sebastian ; et al. | 2010-04-01 |
| Tc and Re Labeled Radioactive Glycosylated Octreotide Derivatives App 20090324497 - Wester; Hans-Jurgen ; et al. | 2009-12-31 |
| Tc and Re labeler radioactive glycosylated octreotide derivatives Grant 7,589,061 - Wester , et al. September 15, 2 | 2009-09-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 